Cytodyn Inc (CYDY)

[C-20]

I hope it is better , we need more than one therapeutic to fight this virus with. I wouldn’t jump to any conclusions that it’s better yet. Let’s see how LL does in its 4 dose trial then I think we will know which one is better. I think LL results will be closer to the 82% survival rate it had during the first 14 days which leaves it slightly less effective than this new drug. This will be a win win situation especially if both drugs reach approval, it’s way past time we had something to fight covid 19 that actually works.